Interventional Neurology, also known as Neurovascular Devices, is a non-surgical specialty that uses minimally invasive, image-guided procedures to treat the most intricate and deadly illnesses of the brain, neck, and spine. Patients with neurovascular illnesses, which mostly affect and harm the human brain, have severe changes in the vascular architecture of their neural tissues and blood vessels.
The market for neurovascular devices in 2021 was worth USD 2.82 billion, and by 2030 it will be worth USD 5.92 billion, growing at a 8.6% CAGR during the forecast period.
The expansion of the neurovascular devices market has been positively impacted by factors like proactive government initiatives, rising consumer awareness, and significant demand for minimally invasive surgeries. During the projection period, the market will grow due to the development of healthcare technology and the rise in neurovascular aradığınız en guzel Rus Escort Bayan Liza – Avrupa Yakası | İstanbul Escort Bayan sizlerle burada bulusuyor. treatments performed worldwide. Demand for neurovascular devices will increase with the growing geriatric population.
Market Dynamics
Drivers
The market for neurovascular devices is expanding due to the increasing frequency of neurovascular illnesses among the world’s population. Neurological devices are frequently used to diagnose and treat diseases of the brain and central nervous system. The demand for neurovascular devices is increasing due to the growing acceptance of minimally invasive operations as a result of technological developments in the field of neurology. The rising prevalence of neurological conditions like stroke, epilepsy, and cerebral aneurysm in the general population is driving the need for neurovascular devices.
The creation and expanded use of neurovascular devices result from rising corporate and government investments in the research and development of sophisticated healthcare infrastructure and infrastructure. The existence of technologically enhanced neurovascular devices has substantially aided in the development of advanced treatments for a variety of neurological illnesses.
Restraints
The use of neurovascular devices in small institutions is constrained by the high cost of treating neurovascular illnesses, maintenance costs, and other indirect costs. Only a few people can afford therapy for neurological illnesses due to limited funding options.
Opportunity
Innovative technologies will continue to broaden the spectrum of neurovascular devices available for treating various aneurysm types safely and efficiently. Aneurysm management is always improving, with sophisticated technology at the forefront of innovation. According to the Southwestern Medical Center, approximately 795,000 people in the United States suffer from a stroke each year. The increased efficacy of the tools produced will lower the mortality rate caused by stroke.
Market Segmentation
By Device
In 2022, the cerebral embolization and aneurysm coiling devices segment led the market with a revenue share of nearly 34.79%. Aneurysms can be treated using coil embolization, a minimally invasive technique that seals the sac and lowers the risk of bleeding. The increasing rate of the aneurysm will drive segment growth throughout the forecast period.
The neuro-thrombectomy devices segment will grow at the greatest CAGR over the forecast period. This segment will expand due to an increase in growth tactics used by the major market players, including product launches, mergers and acquisitions, and a rise in the incidence of acute ischemic stroke.
By Therapeutic Application
Due to factors such as the rising frequency of hypertension, stroke, and other neurological illnesses, stroke held the biggest market share of nearly 57.10% in 2022. Strokes are the second largest cause of mortality worldwide and are responsible for over 140,000 fatalities annually in the United States. The global government has launched several programs to avoid stroke. Examples include the National Institute of Neurological Stroke awarding a new USD 11.3 million grant to the Udall Center at the University of Minnesota Medical School in October 2021.
By End-Use
In 2022, the hospital segment was the biggest market, with a revenue share of nearly 70.95%. The largest share of this segment is due to the rise in patients with neurovascular conditions. Such as ischemic and hemorrhagic stroke, brain aneurysms, traumatic brain injury (TBI), and arteriovenous malformation. For instance, the World Stroke Organization estimates that 1 in 4 people. Above 25 will have a stroke at some point in their lifetime.
Regional Analysis
North America was the market leader in 2022. With a revenue share of nearly 26.44% due to the presence of major companies in the region. Including Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit medical systems, Inc. According to Phenoxy Inc., the FDA has approved the use of their preset. Thrombectomy Device for the treatment of acute ischemic stroke. Additionally, the market for neurovascular devices is growing in this region due to the increased frequency of neurological illnesses. And the rising desire for minimally invasive surgical treatments.
Key Players
- Stryker
- Terumo Corporation
- Inc.
- Medtronic Plc
- Micro Port Scientific Corporation
- Johnson & Johnson Corporation
- Merit Medical Systems
- Gore & Associates Inc.
- Others
The market for neurovascular devices in 2021 was worth USD 2.82 billion. And by 2030 it will be worth USD 5.92 billion, growing at a 8.6% CAGR during the forecast period. The market for neurovascular devices is stimulated by the rising incidence of neurological diseases, technical advancements. And rising interest in minimally invasive procedures.
Interventional nervous system science gadgets are utilized to analyze and treat focal sensory system and cerebrum vascular issues. Endovascular, catheter-based strategies, angiography, and fluoroscopy are all essential for the interventional nervous system science. Catheter angiography is one of the most seasoned in-vivo cerebrum vascular imaging procedures used to analyze various neurological illnesses including cerebral aneurysm, arteriovenous distortions, intracranial aradığınız en guzel Beylikdüzü Yeni ve Genç Escort Cansel | İstanbul Escort Bayan sizlerle burada bulusuyor. stenosis, arteriovenous fistula, and vasculitis.
Expansion in occurrences of neurological problems like mind/cerebral aneurysm, strokes, epilepsy among numerous others in a few nations is supposed to drive the neurovascular gadgets market development. As per the NHS Britain, around 1 out of 12,500 individuals in Britain have burst mind aneurysm consistently. Moreover, cerebrum aneurysm influences roughly 3.0% of the people in the U.K..
Around 40.0% of cracks bring about death and roughly 66.0% of the individuals who endure has some long-lasting cerebrum harm. Accordingly, the quickly and huge developing patient populace base for the objective infections across the key business sectors is essentially liable for the critical volume utilization of neurovascular gadgets, prompting the market development.
Related Reports:
Bakery Processing Equipment Market Report – The global bakery processing equipment market will witness a robust CAGR of 5.91%, valued at $13.02 billion in 2021. Expected to appreciate and reach $21.82 billion by 2030, confirms Strategic Market Research.
